Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1

[img]
15yrfollowup%20copy[1].pdf - Submitted Version (157kB)
Restricted to Repository staff only

Vassilaros, S, Tsibanis, A, Tsikkinis, A, Pietersz, GA, McKenzie, IFC and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2013) Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1. Immunotherapy, 5 (11). 1177 - 1182. ISSN 1750-743X

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/33967
DOI https://doi.org/10.2217/imt.13.126
Official URL https://www.futuremedicine.com/doi/10.2217/imt.13....
Subjects Current > FOR Classification > 1107 Immunology
Historical > Faculty/School/Research Centre/Department > Centre for Chronic Disease Prevention and Management
Current > Division/Research > Other
Keywords Mucin 1; glycoproteins; vaccines; vaccination
Citations in Scopus 64 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login